New York Stem Cell Foundation Inc.
New York, NY
- UEI
- ZCKCL8KFL3B9
- CAGE
- 5FLH1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
New York Stem Cell Foundation Inc.
ZCKCL8KFL3B9
- Cellray LLC FUXSTUMKHHY7
- Cellray Technologies Inc. LXF6FKKMR3A8
-
New York Stem Cell Foundation Inc.
ZCKCL8KFL3B9
- SAM.gov registration date
- Physical address
- 619 W 54th St, New York, NY 10019, USA
- Website
- nyscf.org
- Founded
- 2005
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Financials
- Diversified Financials
- Capital Markets
- Fundraising
- SIC code
- 67 Holding & Other Investment Offices
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Ipsc generation and beta cell differentiation | National Heart Lung and Blood Institute | $0 | |
| New york stem cell foundation, the:1210698 [24-005633] | National Human Genome Research Institute | $15,375 | |
| Digeorge syndrome (DGS) patient derived induced pluripotent stem cells (ipscs) | National Heart Lung and Blood Institute | $26,250 | |
| New york stem cell foundation, the:1210698 [23-004533] | National Institute on Drug Abuse | $105,000 | |
| Generate alzheimer's disease and related dementia (adrd) patient-derived ipsc lines | National Institute on Drug Abuse | $69,850 |
About New York Stem Cell Foundation Inc.
New York Stem Cell Foundation Inc. is a non-profit organization and foundation registered in SAM.gov since 2009, specializing in advanced stem cell research and related scientific services. The organization focuses on generating induced pluripotent stem cell (iPSC) lines, differentiating stem cells into specialized cell types, and conducting comprehensive research across various medical domains. Its primary service offerings to the federal government involve generating patient-derived stem cell lines, developing cell differentiation protocols, and performing advanced cellular research and characterization for multiple National Institutes of Health (NIH) agencies.
Through federal contract awards, New York Stem Cell Foundation Inc. has consistently provided specialized stem cell research services to multiple NIH agencies, including the National Human Genome Research Institute, National Institute on Drug Abuse, National Institute on Aging, and National Institute of Dental and Craniofacial Research. The organization's contract work spans generating induced pluripotent stem cell lines from patients with various conditions such as Alzheimer's disease, DiGeorge Syndrome, psychiatric disorders, and diabetes. Contract values have ranged from $15,375 to $3.4 million, with most awards structured as firm fixed-price purchase orders or definitive contracts. No set-aside designations were used in these contract awards, and the work primarily involves cell line generation, differentiation of stem cells into specific cell types like beta cells and neural progenitor cells, and comprehensive cellular research and validation.
Regarding federal grant sub-awards, the organization has been involved in collaborative research projects, such as a recent sub-award from the Icahn School of Medicine at Mount Sinai focused on developing post-traumatic stress disorder (PTSD) models. The grant work involves deriving and reprogramming fibroblast samples, differentiating induced pluripotent stem cells into various cell types like glutamatergic, GABAergic, and astrocytes, and developing high-throughput, high-content imaging assays. The research emphasizes a collaborative approach, incorporating biologists, automation engineers, software engineers, and data scientists to uncover new understandings of complex medical conditions. While the provided data focuses on a single sub-award, it demonstrates the organization's commitment to interdisciplinary research and advanced cellular modeling techniques.
Contract vehicles
Quick answers
What is New York Stem Cell Foundation Inc.'s UEI?
New York Stem Cell Foundation Inc.'s Unique Entity ID (UEI) in SAM.gov is ZCKCL8KFL3B9.
What is New York Stem Cell Foundation Inc.'s CAGE code?
New York Stem Cell Foundation Inc.'s CAGE code is 5FLH1.
What is New York Stem Cell Foundation Inc.'s primary NAICS code?
New York Stem Cell Foundation Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is New York Stem Cell Foundation Inc. located?
New York Stem Cell Foundation Inc.'s physical address in SAM.gov is 619 W 54th St, New York, NY 10019, USA.
Is New York Stem Cell Foundation Inc. registered in SAM.gov?
Yes. New York Stem Cell Foundation Inc.'s SAM.gov registration is active through November 13, 2026.
Which contract vehicles does New York Stem Cell Foundation Inc. hold?
New York Stem Cell Foundation Inc. holds a place on 1 federal contract vehicle: Gene Insertion - Pluripotent Stem Cells 2012-2017.
What is New York Stem Cell Foundation Inc.'s most recent federal award?
New York Stem Cell Foundation Inc.'s most recent federal contract award is Ipsc generation and beta cell differentiation (75N92025P00392), from National Heart Lung and Blood Institute, on September 25, 2025.
On GovTribe
See New York Stem Cell Foundation Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors